+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amrinone for Injection Market - Global Forecast 2026-2032- Product Image
Amrinone for Injection Market - Global Forecast 2026-2032- Product Image
Sale

Amrinone for Injection Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6134481
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Amrinone for Injection Market is projected to reach USD 247.44 Million in 2026. It is expected to continue growing at a CAGR of 5.23%, reaching USD 335.83 Million by 2032.

Amrinone for Injection: Executive Overview

Amrinone for injection is an intravenous inotropic and vasodilator therapy historically associated with short-term management of severe heart-failure states and selected low-output cardiac conditions. Its clinical relevance depends on the treatment setting, local approval status, institutional protocols, and the availability of alternative inotropes and mechanical circulatory support. Assessment should therefore focus on evidence, safety monitoring, procurement continuity, and appropriate patient selection rather than broad utilization assumptions.

Clinical Practice Is Shifting Toward Tightly Defined Use

The landscape is shaped by heightened attention to evidence-based acute cardiac care, hemodynamic monitoring, and risk management. Clinicians increasingly evaluate inotropic therapy against alternatives, including other pharmacologic agents and device-supported interventions, while considering arrhythmia risk, hypotension, thrombocytopenia, and organ-function constraints. Regulatory status and product availability also vary across jurisdictions, making formulary governance and institutional expertise important determinants of access.

Artificial Intelligence Can Strengthen Safety and Stewardship

Artificial intelligence can support, but not replace, specialist judgment in amrinone-related care. Potential applications include identifying patients at risk of hemodynamic deterioration, integrating laboratory and monitoring data, detecting adverse-event patterns, and improving medication-reconciliation workflows. Responsible deployment requires clinically validated models, transparent escalation rules, secure data handling, and continuous review for bias and false alarms. AI should remain an adjunct to bedside assessment and established prescribing protocols.

Regional Differences Center on Access, Evidence, and Critical-Care Capacity

North America generally benefits from advanced cardiac-care infrastructure, but use is constrained by formulary decisions, labeling requirements, and competition from alternative therapies. Europe’s practice is influenced by national and European regulatory frameworks, health-technology assessment, and strong pharmacovigilance expectations. Asia-Pacific presents varied access, manufacturing, and intensive-care capabilities across markets. Latin America may experience differences in procurement reliability and specialist availability. In the Middle East, tertiary-care concentration and import dependence can shape access, while Africa often faces wider constraints in critical-care capacity, diagnostics, and continuous medicine supply. Across all regions, locally verified regulatory and procurement data are essential.

Economic and Security Groups Have Distinct Coordination Needs

ASEAN members may benefit from stronger regional approaches to registration, supply continuity, and critical-care training, while BRICS economies span substantial differences in domestic production, regulatory maturity, and hospital capability. European Union systems operate within shared regulatory structures but retain national purchasing and reimbursement decisions. G7 countries generally have sophisticated pharmacovigilance and intensive-care systems, although access and formulary policies remain nationally determined. GCC states often combine advanced tertiary facilities with reliance on coordinated procurement and imports. NATO members require resilient medical logistics and continuity planning for civilian and operational healthcare settings, without implying uniform clinical practice across the alliance.

Country Contexts Require Local Verification Before Adoption Decisions

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States require review of national authorization, hospital formularies, clinical guidance, and supply status. Brazil, China, India, Mexico, and Russia may show additional variation in registration pathways, public and private procurement, domestic manufacturing, and specialist access. Country-level assessment should verify the current product label, approved indications, pharmacovigilance requirements, import or distribution conditions, and availability of alternative therapies. These factors can materially influence responsible use and should not be inferred solely from regional or economic-group membership.

Prioritize Governance, Supply Resilience, and Clinician Readiness

Industry leaders should maintain current regulatory dossiers and map country-specific availability before pursuing access or procurement initiatives. Hospitals and health systems should use multidisciplinary protocols covering patient selection, dosing, infusion monitoring, contraindications, adverse-event response, and transition planning. Supply strategies should include qualified suppliers, contingency inventory rules, quality documentation, and early-warning monitoring for shortages. Evidence generation should focus on clinically meaningful outcomes and real-world safety, while AI initiatives should begin with narrow, auditable use cases supported by clinician oversight and cybersecurity controls.

Methodology: Evidence-Based, Jurisdiction-Specific Assessment

This executive summary uses a structured review framework for amrinone for injection, emphasizing verified regulatory information, clinical literature, pharmacovigilance sources, institutional guidance, procurement documentation, and publicly available health-system materials. Findings are organized across clinical practice, technology, regions, economic groups, and countries. Because authorization, availability, and standards can change, conclusions should be validated against current national regulators, hospital formularies, official shortage notices, and peer-reviewed evidence before operational decisions are made. No market estimates, market sizing, market shares, or forecasts are used.

Responsible Use Depends on Evidence, Infrastructure, and Local Context

Amrinone for injection occupies a specialized position in acute cardiovascular care, where treatment decisions are highly dependent on patient condition, monitoring capability, alternatives, and jurisdictional requirements. The most durable priorities are rigorous governance, reliable supply, specialist training, transparent safety surveillance, and carefully controlled digital support. Leaders should treat local verification and continuous clinical review as prerequisites for any access, procurement, or implementation decision.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Amrinone for Injection Market, by Dosage Form
7.1. Introduction
7.2. Lyophilized Powder
7.2.1. Cartridge
7.2.2. Vial
7.3. Solution For Injection
8. Amrinone for Injection Market, by Indication
8.1. Introduction
8.2. Acute Heart Failure
8.3. Cardiogenic Shock
8.4. Chronic Heart Failure
8.4.1. Diastolic Dysfunction
8.4.2. Systolic Dysfunction
9. Amrinone for Injection Market, by End User
9.1. Introduction
9.2. Ambulatory Care Centers
9.3. Hospitals
9.3.1. Government Hospitals
9.3.2. Private Hospitals
9.4. Specialty Clinics
9.4.1. Cardiac Clinics
9.4.2. Cardiology Centers
10. Amrinone for Injection Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Amrinone for Injection Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Amrinone for Injection Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Alkem Laboratories Ltd.
14.2. Amneal Pharmaceuticals LLC
14.3. AstraZeneca PLC
14.4. Baxter International Inc.
14.5. Bayer AG
14.6. Boehringer Ingelheim International GmbH
14.7. Cipla Limited
14.8. Dr. Reddy’s Laboratories Ltd.
14.9. Eli Lilly and Company
14.10. Endo International plc
14.11. Fresenius Kabi AG
14.12. GlaxoSmithKline plc
14.13. Hospira, Inc.
14.14. Johnson & Johnson Services, Inc.
14.15. Lupin Limited
14.16. Macarthur Medical Supply Pty Ltd
14.17. Merck Sharp & Dohme Corp.
14.18. Mylan N.V.
14.19. Mylan Pharmaceuticals Inc.
14.20. Novartis AG
14.21. Pfizer Inc.
14.22. Pfizer Ireland Pharmaceuticals
14.23. Recipharm AB
14.24. Roche Holding AG
14.25. Sandoz International GmbH
14.26. Sanofi-Aventis Deutschland GmbH
14.27. Siegfried Holding AG
14.28. SteriMax, Inc.
14.29. Sun Pharmaceutical Industries Ltd.
14.30. Takeda Pharmaceutical Company Limited
14.31. Teva Pharmaceutical Industries Ltd.
14.32. Zydus Lifesciences Limited
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Amrinone for Injection Market, Years Considered for the Study
FIGURE 2. Global Amrinone for Injection Market, Research Design
FIGURE 3. Global Amrinone for Injection Market, Research Framework
FIGURE 4. Global Amrinone for Injection Market, Data Triangulation
FIGURE 5. Global Amrinone for Injection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Amrinone for Injection Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 7. Global Amrinone for Injection Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Amrinone for Injection Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 9. Global Amrinone for Injection Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Amrinone for Injection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Amrinone for Injection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Amrinone for Injection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Amrinone for Injection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Amrinone for Injection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Amrinone for Injection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Amrinone for Injection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Amrinone for Injection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Amrinone for Injection Market Segmentation & Coverage
TABLE 2. Global Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 4. Global Lyophilized Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Lyophilized Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Lyophilized Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Cartridge Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Cartridge Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Cartridge Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Solution For Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Solution For Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Solution For Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 17. Global Acute Heart Failure Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Acute Heart Failure Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Acute Heart Failure Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Cardiogenic Shock Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Cardiogenic Shock Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Cardiogenic Shock Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Chronic Heart Failure Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Chronic Heart Failure Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Chronic Heart Failure Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Diastolic Dysfunction Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Diastolic Dysfunction Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Diastolic Dysfunction Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Systolic Dysfunction Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Systolic Dysfunction Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Systolic Dysfunction Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 33. Global Ambulatory Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Ambulatory Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Ambulatory Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Government Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Government Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Government Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Cardiac Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Cardiac Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Cardiac Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Cardiology Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Cardiology Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Cardiology Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Amrinone for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Amrinone for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 63. North America Amrinone for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. North America Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 65. North America Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 66. North America Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 67. North America Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 68. North America Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. North America Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 70. North America Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 71. Latin America Amrinone for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Latin America Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 73. Latin America Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 74. Latin America Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 75. Latin America Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 76. Latin America Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Latin America Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 78. Latin America Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 79. Europe Amrinone for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Europe Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 81. Europe Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 82. Europe Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 83. Europe Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 84. Europe Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Europe Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 86. Europe Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 87. Middle East Amrinone for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Middle East Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 89. Middle East Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 90. Middle East Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 91. Middle East Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 92. Middle East Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Middle East Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 94. Middle East Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 95. Africa Amrinone for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Africa Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 97. Africa Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 98. Africa Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 99. Africa Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 100. Africa Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Africa Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 102. Africa Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 103. Global Amrinone for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. ASEAN Amrinone for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. ASEAN Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 106. ASEAN Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 107. ASEAN Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 108. ASEAN Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 109. ASEAN Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. ASEAN Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 111. ASEAN Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 112. GCC Amrinone for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. GCC Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 114. GCC Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 115. GCC Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 116. GCC Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 117. GCC Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. GCC Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 119. GCC Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 120. European Union Amrinone for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. European Union Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 122. European Union Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 123. European Union Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 124. European Union Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 125. European Union Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. European Union Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 127. European Union Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 128. BRICS Amrinone for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. BRICS Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 130. BRICS Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 131. BRICS Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 132. BRICS Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 133. BRICS Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. BRICS Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 135. BRICS Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 136. G7 Amrinone for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. G7 Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 138. G7 Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 139. G7 Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 140. G7 Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 141. G7 Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. G7 Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 143. G7 Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 144. NATO Amrinone for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. NATO Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 146. NATO Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 147. NATO Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 148. NATO Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 149. NATO Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. NATO Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 151. NATO Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 152. Global Amrinone for Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. United States Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 154. United States Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 155. United States Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 156. United States Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 157. United States Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 158. United States Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. United States Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 160. United States Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 161. Canada Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 162. Canada Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 163. Canada Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 164. Canada Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 165. Canada Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 166. Canada Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Canada Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 168. Canada Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 169. Mexico Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 170. Mexico Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 171. Mexico Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 172. Mexico Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 173. Mexico Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 174. Mexico Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Mexico Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 176. Mexico Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 177. Brazil Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 178. Brazil Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 179. Brazil Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 180. Brazil Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 181. Brazil Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 182. Brazil Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. Brazil Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 184. Brazil Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 185. United Kingdom Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 186. United Kingdom Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 187. United Kingdom Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 188. United Kingdom Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 189. United Kingdom Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 190. United Kingdom Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. United Kingdom Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 192. United Kingdom Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 193. Germany Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 194. Germany Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 195. Germany Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 196. Germany Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 197. Germany Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 198. Germany Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Germany Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 200. Germany Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 201. France Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 202. France Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 203. France Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 204. France Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 205. France Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 206. France Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. France Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 208. France Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 209. Russia Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 210. Russia Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 211. Russia Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 212. Russia Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 213. Russia Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 214. Russia Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. Russia Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 216. Russia Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 217. Italy Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 218. Italy Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 219. Italy Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 220. Italy Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 221. Italy Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 222. Italy Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Italy Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 224. Italy Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 225. Spain Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 226. Spain Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 227. Spain Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 228. Spain Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 229. Spain Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 230. Spain Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Spain Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 232. Spain Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 233. China Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 234. China Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 235. China Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 236. China Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 237. China Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 238. China Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. China Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 240. China Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 241. India Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 242. India Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 243. India Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 244. India Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 245. India Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 246. India Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. India Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 248. India Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 249. Japan Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 250. Japan Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 251. Japan Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 252. Japan Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 253. Japan Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 254. Japan Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. Japan Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 256. Japan Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 257. Australia Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 258. Australia Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 259. Australia Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 260. Australia Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 261. Australia Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 262. Australia Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Australia Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 264. Australia Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 265. South Korea Amrinone for Injection Market Size, 2017-2032 (USD Million)
TABLE 266. South Korea Amrinone for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 267. South Korea Amrinone for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 268. South Korea Amrinone for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 269. South Korea Amrinone for Injection Market Size, by Chronic Heart Failure, 2017-2032 (USD Million)
TABLE 270. South Korea Amrinone for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. South Korea Amrinone for Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 272. South Korea Amrinone for Injection Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 273. Global Amrinone for Injection Market Share, by Key Player, 2025
TABLE 274. Global Amrinone for Injection Market, Key Experts

Companies Mentioned

  • Alkem Laboratories Ltd.
  • Amneal Pharmaceuticals LLC
  • AstraZeneca PLC
  • Baxter International Inc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • Endo International plc
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Hospira, Inc.
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Macarthur Medical Supply Pty Ltd
  • Merck Sharp & Dohme Corp.
  • Mylan N.V.
  • Mylan Pharmaceuticals Inc.
  • Novartis AG
  • Pfizer Inc.
  • Pfizer Ireland Pharmaceuticals
  • Recipharm AB
  • Roche Holding AG
  • Sandoz International GmbH
  • Sanofi‑Aventis Deutschland GmbH
  • Siegfried Holding AG
  • SteriMax, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Lifesciences Limited

Related Topics

Related Reports

Colistimethate Sodium for Injection Market - Global Forecast 2026-2032 - Product Image

Colistimethate Sodium for Injection Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Recombinant Human Growth Hormone Injections Market - Global Forecast 2026-2032 - Product Image

Recombinant Human Growth Hormone Injections Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Insulin Injection Aids - Global Strategic Business Report - Product Image

Insulin Injection Aids - Global Strategic Business Report

  • Report
  • 280 Pages
  • Global
From
Injection Pens - Global Strategic Business Report - Product Image

Injection Pens - Global Strategic Business Report

  • Report
  • 355 Pages
  • Global
From
Botulinum Toxin Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Botulinum Toxin Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 118 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.